90 related articles for article (PubMed ID: 6121011)
1. Biochemical evidence for alteration of neostriatal dopaminergic function by 5,7-dihydroxytryptamine.
Liston DR; Franz DN; Gibb JW
J Neurochem; 1982 May; 38(5):1329-35. PubMed ID: 6121011
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
3. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
4. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
[TBL] [Abstract][Full Text] [Related]
5. Effect of intranigral administration of 6-hydroxydopamine and 5,7-dihydroxytryptamine on rat brain tryptamine.
Juorio AV; Greenshaw AJ; Nguyen TV
J Neurochem; 1987 May; 48(5):1346-50. PubMed ID: 3104539
[TBL] [Abstract][Full Text] [Related]
6. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
7. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
8. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
9. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
Schmidt CJ; Gibb JW
Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
Johnson M; Hanson GR; Gibb JW
Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
[TBL] [Abstract][Full Text] [Related]
11. Changes in activity and mRNA for rat tryptophan hydroxylase and aromatic L-amino acid decarboxylase of brain serotonergic cell bodies and terminals following neonatal 5,7-dihydroxytryptamine.
Park DH; Stone DM; Baker H; Wessel TC; Kim KS; Towle AC; Joh TH
Brain Res; 1993 Apr; 609(1-2):59-66. PubMed ID: 8508321
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nigrostriatal dopamine pathways of chronically food-restricted rats.
Pan Y; Berman Y; Haberny S; Meller E; Carr KD
Brain Res; 2006 Nov; 1122(1):135-42. PubMed ID: 17010321
[TBL] [Abstract][Full Text] [Related]
13. Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brain.
Manaker S; Engber TM; Knight PB; Winokur A
J Neurochem; 1985 Oct; 45(4):1315-8. PubMed ID: 3928818
[TBL] [Abstract][Full Text] [Related]
14. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
Nielsen JA; Moore KE
Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
[TBL] [Abstract][Full Text] [Related]
15. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
Kogan FJ; Nichols WK; Gibb JW
Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
[TBL] [Abstract][Full Text] [Related]
16. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.
Johnson M; Stone DM; Hanson GR; Gibb JW
Eur J Pharmacol; 1987 Mar; 135(2):231-4. PubMed ID: 2884120
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.
Hotchkiss AJ; Gibb JW
J Pharmacol Exp Ther; 1980 Aug; 214(2):257-62. PubMed ID: 6104722
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan hydroxylase in hippocampus and midbrain following unilateral injection of 5,7-dihydroxytryptamine.
Clewans CS; Azmitia E
Brain Res; 1984 Jul; 307(1-2):125-33. PubMed ID: 6466991
[TBL] [Abstract][Full Text] [Related]
19. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine.
Ricaurte GA; Fuller RW; Perry KW; Seiden LS; Schuster CR
Neuropharmacology; 1983 Oct; 22(10):1165-9. PubMed ID: 6606137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
